Masters of Rhetorical Knowledgeability by Claire Harrison

Get full text

JAK inhibitors and myelofibrosis, Einstein and ruxolitinib by Claire Harrison

Get full text

Myeloproliferative neoplasms and personalized medicine: the perfect match? by Jean-Jacques Kiladjian, Claire Harrison

Get full text

JAK inhibitors: beyond spleen and symptoms? by Francisco Cervantes, Ruben Mesa, Claire Harrison

Get full text

Bone marrow niche dysregulation in myeloproliferative neoplasms by Natalia Curto-Garcia, Claire Harrison, Donal P McLornan

Get full text

Pulmonary arterial hypertension exacerbated by ruxolitinib by Andrew T. Low, Luke Howard, Claire Harrison, Robert M.R. Tulloh

Get full text

Ruxolitinib for the Treatment of Essential Thrombocythemia by Arief Gunawan, Patrick Harrington, Natalia Garcia-Curto, Donal McLornan, Deepti Radia, Claire Harrison

Get full text

PB2185: EFFECT OF NEW OR WORSENING ANEMIA ON CLINICAL OUTCOMES IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH RUXOLITINIB (RUX): A POST HOC ANALYSIS OF THE COMFORT-I AND -II TRIA... by Haifa Kathrin Al-Ali, Ruben Mesa, J.E. Hamer-Maansson, Evan Braunstein, Claire Harrison

Get full text

Treatment of Myeloproliferative Neoplasms With Janus Kinase Inhibitors: A Meta‐Analysis of Cardiovascular Safety by Roberta Dunn, Edouard Long, Laura Li Gagnon, Claire Harrison, Yunfan Yang, Jennifer O'Sullivan

Get full text

Changes in Pain and Nutritional Intake Modulate Ultra-Running Performance: A Case Report by Russ Best, Benjamin Barwick, Alice Best, Nicolas Berger, Claire Harrison, Matthew Wright, Julie Sparrow

Get full text

Advances in myelofibrosis: a clinical case approach by John O. Mascarenhas, Attilio Orazi, Kapil N. Bhalla, Richard E. Champlin, Claire Harrison, Ronald Hoffman

Get full text

Pegylated interferon alpha-2a for essential thrombocythemia during pregnancy: outcome and safety. A case series by Yan Beauverd, Deepti Radia, Catherine Cargo, Steve Knapper, Mark Drummond, Arvind Pillai, Claire Harrison, Susan Robinson

Get full text

Combination therapy of hydroxycarbamide with anagrelide in patients with essential thrombocythemia in the evaluation of Xagrid® efficacy and long-term safety study by Luigi Gugliotta, Carlos Besses, Martin Griesshammer, Claire Harrison, Jean-Jacques Kiladjian, Ruth Coll, Jonathan Smith, Brihad Abhyankar, Gunnar Birgegård

Get full text

P1044: REDUCTION IN RED BLOOD CELL TRANSFUSION BURDEN: A NOVEL LONGITUDINAL TIME-DEPENDENT ANALYSIS IN PATIENTS WITH TRANSFUSION-DEPENDENT MYELOFIBROSIS TREATED WITH MOMELOTINIB by Claire Harrison, Ruben Mesa, Moshe Talpaz, Vikas Gupta, Aaron T. Gerds, Barbara Klencke, Catherine Ellis, Jun Kawashima, Rafe Donahue, Bryan Strouse, Stephen Oh

Get full text

P1057: INDIRECT TREATMENT COMPARISONS OF MOMELOTINIB VS PACRITINIB SAFETY AND ANEMIA OUTCOMES IN PATIENTS WITH MYELOFIBROSIS by Lucia Masarova, Srdan Verstovsek, Francesca Palandri, Ruben Mesa, Claire Harrison, Balazs Dobi, Boris Gorsh, Zhaohui Wang, Catherine Ellis, Dwaipayan Patnaik, Venediktos Kapetanakis

Get full text

The impact of anemia on overall survival in patients with myelofibrosis treated with ruxolitinib in the COMFORT studies by Vikas Gupta, Claire Harrison, Elizabeth O. Hexner, Haifa Kathrin Al-Ali, Lynda Foltz, Michael Montgomery, William Sun, Prashanth Gopalakrishna, Hagop Kantarjian, Srdan Verstovsek

Get full text

P1024: MYLOX-1: A PHASE II STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL LOXL2 INHIBITOR GB2064 (WITH FOCUS ON BONE MARROW COLLAGEN) IN P... by Claire Harrison, John Mascarenhas, Daniela Cilloni, Richard Schlenk, Brian Jacoby, Robert J Slack, Vassilios Aslanis, Bhupinder Singh, Bertil Lindmark, Srdan Verstovsek, Raajit K Rampal

Get full text

Identification of high oxygen affinity hemoglobin variants in the investigation of patients with erythrocytosis by Melanie J. Percy, Nauman N. Butt, Gerard M. Crotty, Mark W. Drummond, Claire Harrison, Gail L. Jones, Matthew Turner, Jonathan Wallis, Mary Frances McMullin

Get full text

P1062: INDIRECT TREATMENT COMPARISON OF MOMELOTINIB VS FEDRATINIB SAFETY IN PATIENTS WITH MYELOFIBROSIS by Francesca Palandri, Lucia Masarova, Srdan Verstovsek, Ruben Mesa, Claire Harrison, Gautam Sajeev, Boris Gorsh, Ryan Simpson, Sang Cho, Zhaohui Wang, Catherine Ellis, Sean Conlon, James Signorovitch

Get full text

P1030: SPLEEN VOLUME REDUCTION PREDICTS SURVIVAL IN MYELOFIBROSIS PATIENTS ON PACRITINIB BUT NOT BEST AVAILABLE THERAPY: PERSIST-2 LANDMARK OVERALL SURVIVAL ANALYSIS by Jan Bewersdorf, Helen Ajufo, Claire Harrison, Francesca Palandri, John Mascarenhas, Jeanne Palmer, Aaron T. Gerds, Jean-Jacques Kiladjian, Andrii Derkach, Karisse Roman-Torres, Sarah Buckley, Raajit K Rampal

Get full text